Orikine Bio
Isabel Jiménez Bernal is a seasoned professional in the healthcare sector with extensive experience in investment analysis and biotech development. Currently serving as a Senior Investment Associate at Asabys Partners since July 2022, Isabel evaluates innovative investment opportunities. In addition, Isabel holds board observer roles at Augustine Therapeutics, Orikine Bio, and Cara Care, where contributions to the development of novel therapies and digital health solutions are made. Previous experience includes an investment analyst position at Ysios Capital and a research role at the Vall d´Hebron Institute of Oncology, where a PhD in Medicine was obtained. Isabel possesses an MBA from Esade and relevant degrees in advanced immunology and biochemistry from the Universitat Autònoma de Barcelona, Universitat de Barcelona, and Universidad de Zaragoza.
This person is not in the org chart
This person is not in any teams
Orikine Bio
Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe.